P03-025 – Differential diagnosis of autoimmune disorders
© Kozlova et al; licensee BioMed Central Ltd. 2013
Published: 8 November 2013
Mendelian susceptibility to mycobacterial disease (MSMD) is a rare form of primary immunodeficiencies characterized by predisposition for poorly virulent infection agents, primarily non-tuberculous mycobacteria and Salmonella. It has been shown that molecular basis of these diseases is mutations in at least 7 genes in the IL12-dependent IFN-g axis including IFNGR1, IFNGR2, IL-12/IL23RB1, IL-12B, IRF8, NEMO, CYBB and STAT1. There are about 140 patients with IL-12Rb1/IL-23Rb1 deficiency reported up to date, who manifest with various nonspecific inflammatory features due to chronic BCG infection and salmonellosis.
Here we report two patients ages 4 and 8 who were referred to us with preliminary diagnosis of autoimmune disorder and very similar symptoms of enlarged lymph nodes of several groups, recurrent fever and vasculitic rash on extremities. In the second patient the skin rash was considered a manifestation of vasculitis and, as a result, she was treated with glucocorticoids and azathioprine for more than 5 years with short interruptions and minimal effect. Laboratory tests in both patients showed: anemia 75-100 g/l, increased inflammatory activity (CRP, ESR), hyper-gammaglobylinemia (IgG 27-39.4 g/l; IgA 0.65 – 9.17; IgM 1.5 - 3.11 g/l). Both patients had very high levels of rheumatoid factor (with no arthritis), low levels of C4 complement. ANF levels were normal.
It was known that both patients had regional BCG infection following vaccination in early infancy, that required massive anti-mycobacterial therapy. Salmonellosis complicated by pneumonia was diagnosed at 2 and 6 years of age in the 1st and 2nd patient, respectively.
Upon admission to our Center both patients’ blood cultures were positive for Salmonella D. enteritidis. The extensive anti-bacterial therapy and IFN-g s.c. without any antiinflamatory treatment provided good control of the disease in both girls.
The diagnosis of IL12Rb1 deficiency in these patients was based on in vitro findings of nulle expression of CD212 (IL-12Rb1) on PHA-stimulates T cell blasts, decreased in vitro production of INFg by PHA activated PBMC and was genetically confirmed.
In accessing patients with periodic fever and autoimmune-like features it is important to keep in mind a group of rare primary immunodeficiencies, affecting IL12\IFN gamma axis.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.